Reorienting health systems to care for people with HIV beyond viral suppression
Safreed-Harmon, K., Anderson, J., Azzopardi-Muscat, N., Behrens, G.M.N., d'Arminio Monforte, A., Davidovich, U., del Amo, J., Kall, M., Noori, T., Porter, K., Lazarus, J.V.
HIV among women in the WHO European Region - epidemiological trends and predictors of late diagnosis, 2009-2018
Mårdh, O., Quinten, C., Kuchukhidze, G., Seguy, N., Dara, M., Amato-Gauci, A.J., Pharris, A., On Behalf Of The Ecdc/Who Hiv Surveillance Network
HIV testing strategies employed in health care settings in the European Union/European Economic Area (EU/EEA): evidence from a systematic review
Desai, S., Tavoschi, L., Sullivan, A.K., Combs, L., Raben, D., Delpech, V., Jakobsen, S.F., Amato-Gauci, A.J., Croxford, S.
HIV testing strategies outside of health care settings in the European Union (EU)/European Economic Area (EEA): a systematic review to inform European Centre for Disease Prevention and Control guidance
Croxford, S., Tavoschi, L., Sullivan, A.K., Combs, L., Raben, D., Delpech, V., Jakobsen, S.F., Amato-Gauci, A.J., Desai, S.
Hepatitis B/C in the countries of the EU/EEA: A systematic review of the prevalence among at-risk groups
Falla, A.M., Hofstraat, S.H.I., Duffell, E., Hahné, S.J.M., Tavoschi, L., Veldhuijzen, I.K.
Rapid Risk Assessment: Potential public health risks related to communicable diseases at the WorldPride festival in Madrid, 23 June–2 July 2017
This rapid risk assessment reviews the health risks related to communicable diseases in the context of the WorldPride festival in Madrid, from 23 June to 2 July 2017.
HIV testing in Europe: Evaluating the impact, added value, relevance and usability of the European centre for disease prevention and control (ECDC)’s 2010 HIV testing guidance
Sullivan, A.K., Sperle, I., Raben, D., Amato-Gauci, A.J., Lundgren, J.D., Yazdanpanah, Y., Jakobsen, S.F., Tavoschi, L.
ECDC and EMCDDA technical guidance on prevention and control of infectious diseases among people who inject drugs
The content of this joint guidance was developed by the European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) with the support of a technical advisory group composed of policy makers, service providers, civil society representatives and preventative health experts from throughout the EU/EEA.
ECDC and EMCDDA technical guidance on prevention and control of infectious diseases among people who inject drugs - guidance in brief
This evidence-based guidance is designed to inform the development, monitoring and evaluation of national strategies and programmes in countries in Europe in order to reduce and prevent infections among people who inject drugs.